News FDA plans to phase out animal testing for antibodies The FDA has said it intends to reduce or replace animal testing of some medicines, including monoclonal antibodies, with other methods.
News BenchSci raises $50m to grow AI-powered R&D platform Canadian firm BenchSci has secured around $50 million in third-round financing that will be used to speed up the adoption of its artificial intelligence-powered platform for biomedical rese
Partner Content Partner Content Medicines Discovery Catapult’s Discovery Services platform a... Virtual R&D Discovery Services platform
Partner Content Partner Content Unrivalled imaging capabilities now available to accelerate ... Unrivalled imaging capabilities now available
Partner Content Partner Content SMi’s Europe’s Leading Ophthalmic Conference is only 3 weeks... Europe's Leading Ophthalmic Conference
News NHS "isn't delivering equitable care for rare diseases" A Genetic Alliance UK report claims the NHS is failing to meet the needs of many of the 3.5 million people in the country who live with rare diseases.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.